Navigating equity markets for long-term growth
Unit trust investments capitalise on opportunities in the stock market. By adapting to changing market conditions, these investments aim to provide potential for growth and diversification, helping investors achieve their long-term financial goals.
Managed by
Our dedicated team brings together diverse expertise and insights, ensuring we deliver investment excellence.

Cor Booysen
Equity Portfolio Manager

Deon Botha
Equity Portfolio Manager

Cornelius Zeeman
Equity Portfolio Manager

Donald Curtayne
Equity Portfolio Manager

Chantelle Baptiste
Equity Portfolio Manager & Head of SA Equity Research

Rob Hart
Global Real Estate Equity Portfolio Manager

Clarissa van der Westhuyzen
Equity Portfolio Manager

David Rossouw
Equity Portfolio Manager

Jacques Haasbroek
Equity Portfolio Manager

Stephen Brown
Equity Strategist

Jacobus Lacock
Macro Strategist
GET IN TOUCH
Let us manage your investment journey
Take the next step toward building a resilient financial future. Our team is here to provide any guidance to help you achieve your investment objectives.
Talk to someone



NEWS AND INSIGHTS
Fairtree insights
Explore a wealth of knowledge from our thought leaders, offering in-depth analysis, market trends, and expert commentary to help you navigate the evolving financial landscape.

Fairtree Global Equity Fund Q2 2025 Commentary
US equities ended the quarter 11.2% higher; however, they experienced pronounced volatility following President Donald Trump’s ‘Liberation Day’ announcements of tariffs on imported goods.

Fairtree Equity Explorer | The digital duopoly: Alphabet & Meta in the global ad market | Episode 5
Fairtree Equity Analyst Christoff Marais and Fairtree Global Investment Specialist Karena Naidu will unpack the ever-evolving world of digital advertising.

Fairtree Global Equity Fund Q1 2025 Commentary
The first quarter was turbulent for global equities. The Fund underperformed the benchmark by 65 bps as the benchmark increased by 159 bps, while the Fund increased by 94 bps.

Fairtree Equity Explorer | Rewriting the weight loss playbook with GLP-1s | Episode 4
Janco du Toit & Karena Naidu explore GLP-1 weight loss drugs – once for diabetes, now reshaping obesity treatment – and the leading companies, Eli Lilly and Novo Nordisk.
FAIRTREE NEWSLETTER
Subscribe to our newsletter
Stay informed with expert insights, market updates, and investment perspectives delivered straight to your inbox.
"*" indicates required fields